1146 feeds
357 categories
4211 articles (<24 hours)
25 registered users

Use the Mobile version

Follow our Twitter feed

View our Linkpartners


Register | Retrieve


RSS FeedsRemdesivir `pricing debate` weighs on Celltrion
(WorldNews South Korea)


2 july 2020 15:04:35

Remdesivir `pricing debate` weighs on Celltrion
(WorldNews South Korea)

A lab technician holds COVID-19 treatment remdesivir at Eva Pharma Facility in Cairo, Egypt, on June 25. Reuters-Yonhap Criticism of Gilead compels Korean developers to cut prices By Nam Hyun-woo Gilead Sciences CEO Daniel O`Day / Captured from Gilead Sciences website Korean biotech and pharmaceutical firms working to develop COVID-19 treatments are contemplating how to price their drugs as a result of the fierce debates surrounding the price of remdesivir, a drug created by Gilead Sciences shown to shorten recovery time for severely ill COVID-19 patients. Initially, Gilead said it set the price for remdesivir `far below` the drug`s estimated market value, at least in the United States. An...

14 viewsCategory: General > Asia > South Korea
New fungus boosts Korea`s development of `plastic-chewing` biotech
(WorldNews South Korea)
Lung transplant to COVID-19 patient succeeds in S. Korea
(WorldNews South Korea)
blog comments powered by Disqus

Copyright © 2008 - 2020 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten